817 related articles for article (PubMed ID: 26839235)
1. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL
Clin J Am Soc Nephrol; 2016 Mar; 11(3):505-11. PubMed ID: 26839235
[TBL] [Abstract][Full Text] [Related]
2. Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System.
Sethi S; Najjar R; Peng A; Mirocha J; Vo A; Bunnapradist S; Jordan SC; Huang E
Am J Kidney Dis; 2019 May; 73(5):605-614. PubMed ID: 30929853
[TBL] [Abstract][Full Text] [Related]
3. The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in Australia.
Sypek MP; Kausman JY; Watson N; Wyburn K; Holt SG; Hughes P; Clayton PA
Transplantation; 2021 Jun; 105(6):1317-1325. PubMed ID: 34019363
[TBL] [Abstract][Full Text] [Related]
4. A simplified method of calculating cPRA for kidney allocation application in Hong Kong: a retrospective study.
Chan YP; Wong MWK; Tang LWM; Guo M; Yang W; Ip P; Li PKT; Leung CB; Chau KF; Lam JCK; Yeung NKM; Kwok JSY
Transpl Int; 2017 Dec; 30(12):1234-1242. PubMed ID: 28777478
[TBL] [Abstract][Full Text] [Related]
5. Casting a smaller net into a bigger donor pool: A single center's experience with the new kidney allocation system.
Houp JA; Schillinger KP; Eckstein AJ; Vega RM; Desai NM; Lonze BE; Jackson AM
Hum Immunol; 2017 Jan; 78(1):49-53. PubMed ID: 27890719
[TBL] [Abstract][Full Text] [Related]
6. New priorities: Analysis of the New Kidney Allocation System on UCLA patients transplanted from the deceased donor waitlist.
Hickey MJ; Zheng Y; Valenzuela N; Zhang Q; Krystal C; Lum E; Tsai EW; Lipshutz GS; Gritsch HA; Danovitch G; Veale J; Gjertson D; Cecka M; Reed EF
Hum Immunol; 2017 Jan; 78(1):41-48. PubMed ID: 27818166
[TBL] [Abstract][Full Text] [Related]
7. Increased access to transplantation of highly sensitized patients under the new kidney allocation system. A single center experience.
Colovai AI; Ajaimy M; Kamal LG; Masiakos P; Chan S; Savchik C; Lubetzky M; de Boccardo G; Courson A; Chokechanachaisakul A; Graham J; Greenstein S; Kinkhabwala M; Rocca J; Akalin E
Hum Immunol; 2017 Mar; 78(3):257-262. PubMed ID: 27955974
[TBL] [Abstract][Full Text] [Related]
8. CPRA for allocation of kidneys in the US: More candidates ≥98% CPRA, lower positive crossmatch rates and improved transplant rates for sensitized patients.
Baxter-Lowe LA; Kucheryavaya A; Tyan D; Reinsmoen N
Hum Immunol; 2016 May; 77(5):395-402. PubMed ID: 27012168
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in the highest panel reactive antibody recipients of deceased donor kidneys under the new kidney allocation system.
Parajuli S; Redfield RR; Astor BC; Djamali A; Kaufman DB; Mandelbrot DA
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 27988992
[TBL] [Abstract][Full Text] [Related]
10. Establishment of calculated panel reactive antibody and its potential benefits in improving the kidney allocation strategy in Taiwan.
Shen SW; Chang CK; Gao YS; Hsu PJ; Cheng SC; Liu FY; Lo SC
J Formos Med Assoc; 2017 Dec; 116(12):956-963. PubMed ID: 29037453
[TBL] [Abstract][Full Text] [Related]
11. Parsing the 100% calculated panel reactive antibody kidney transplant candidates: Who gets transplanted?
Keith DS
HLA; 2020 Jan; 95(1):23-29. PubMed ID: 31515960
[TBL] [Abstract][Full Text] [Related]
12. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
[TBL] [Abstract][Full Text] [Related]
13. Calculated panel reactive antibody with decimals: A refined metric of access to transplantation for highly sensitized candidates.
Kransdorf EP; Pando MJ
Hum Immunol; 2017 Mar; 78(3):252-256. PubMed ID: 28069404
[TBL] [Abstract][Full Text] [Related]
14. Stem cell donor HLA typing improves CPRA in kidney allocation.
Kransdorf EP; Pando MJ; Stewart D; Lindblad K; Bray R; Murphey C; Kaur N; Patel JK; Kim I; Zhang X; Maiers M; Kobashigawa JA; Gragert L
Am J Transplant; 2021 Jan; 21(1):138-147. PubMed ID: 32558252
[TBL] [Abstract][Full Text] [Related]
15. Providing Better-Matched Donors for HLA Mismatched Compatible Pairs Through Kidney Paired Donation.
Ferrari P; Cantwell L; Ta J; Woodroffe C; DʼOrsogna L; Holdsworth R
Transplantation; 2017 Mar; 101(3):642-648. PubMed ID: 27077598
[TBL] [Abstract][Full Text] [Related]
16. ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation.
Gragert L; Kadatz M; Alcorn J; Stewart D; Chang D; Gill J; Liwski R; Gebel HM; Gill J; Lan JH
Am J Transplant; 2022 Dec; 22(12):3093-3100. PubMed ID: 35975734
[TBL] [Abstract][Full Text] [Related]
17. The calculated panel reactive antibody policy: an advancement improving organ allocation.
Leffell MS
Curr Opin Organ Transplant; 2011 Aug; 16(4):404-9. PubMed ID: 21666476
[TBL] [Abstract][Full Text] [Related]
18. ABO-incompatible matching significantly enhances transplant rates in kidney paired donation.
Ferrari P; Hughes PD; Cohney SJ; Woodroffe C; Fidler S; D'Orsogna L
Transplantation; 2013 Nov; 96(9):821-6. PubMed ID: 23860086
[TBL] [Abstract][Full Text] [Related]
19. OPO Strategies to Prevent Unintended Use of Kidneys Exported for High PRA (>98% cPRA) Recipients.
Paramesh AS; Neidlinger N; Salvatore M; Smith A; Friedman A; Payne W; Taber T; Wright C
Am J Transplant; 2017 Aug; 17(8):2139-2143. PubMed ID: 28168823
[TBL] [Abstract][Full Text] [Related]
20. Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization?
Schinstock CA; Smith BH; Montgomery RA; Jordan SC; Bentall AJ; Mai M; Khamash HA; Stegall MD
Clin Transplant; 2019 Dec; 33(12):e13751. PubMed ID: 31769104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
